Sort
23,748 grants matching “melanoma”
Enterovirus Vectors with Respiratory Tropism for Cancer Immunotherapy
$234,000Matthias Gromeier · Duke University · R21 · FY2010 · NS
MULTIMODAL GNAQ SIGNALING: PRECISION THERAPY FOR METASTATIC UVEAL MELANOMA PREVENTION AND TREATMENT
$234,000Thomas Jefferson University · · FY2021 · Department of the Army
The role of Absent in Melanoma 2 (Aim2) in CD8+ T cell regulation and Helicobacter-induced gastric pathology
$234,000John Y Kao · University Of Michigan At Ann Arbor · R21 · FY2020 · AI
Clefts/Craniofacial Anomalies and Cancer Susceptibility
$233,998Renato Menezes Silva · University Of Texas Hlth Sci Ctr Houston · R00 · FY2012 · DE
Epigenetic and post-translational regulation of the metastasis suppressor BRMS1
$233,989David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
A PTEN-dependent cell size checkpoint in human cells
$233,970Todd A Waldman · Georgetown University · R01 · FY2014 · CA
Melanoma vaccines
$233,899Karl Erik Hellstrom · University Of Washington · R01 · FY2006 · CA
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
$233,863Brandon James Dekosky · Massachusetts General Hospital · OT2 · FY2024 · CA
PTD-Mediated Protein or Drug Delivery for Cancer Therapy
$233,861Victor C Yang · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
PTD-Mediated Protein or Drug Delivery for Cancer Therapy
$233,861Victor C Yang · University Of Michigan At Ann Arbor · R01 · FY2007 · CA
PTD-Mediated Protein or Drug Delivery for Cancer Therapy
$233,861Victor C Yang · University Of Michigan At Ann Arbor · R01 · FY2008 · CA
Therapy for Liver Cancer by Targeting Energy Metabolism
$233,851Jean-Francois H Geschwind · Johns Hopkins University · R01 · FY2007 · CA
Gene Targeted Therapy of Brain Tumors
$233,754John H Sampson · Duke University · R21 · FY2009 · NS
Cheng - Proj 2
$233,684Chao Cheng · Dartmouth College · P20 · FY2019 · GM
TCR Engineered CD4 Cells as Helpers in Tumor Immunity
$233,650Bijay Mukherji · University Of Connecticut Sch Of Med/Dnt · R01 · FY2010 · CA
Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedema
$233,640Babak J Mehrara · Sloan-Kettering Inst Can Research · R21 · FY2023 · AR
H2 ALPHA GALACTOSYL EPITOPES AND TUMOR METASTASES
$233,598University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
INTEGRINS AND OCULAR ANGIOGENESIS
$233,561Scripps Research Institute · R01 · FY2000 · EY
Targeting the ERK Pathway in KRAS-and BRAF-Driven Lung Cancers
$233,526Neal Rosen · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA
NOVEL APPROACAHES FOR IMPROVING PEDIATRIC BRAFV600E GLIOMA PATIENT OUTCOMES
$233,456Charles David James · University Of California, San Francisco · P50 · FY2016 · CA
MICROCIRCULATION OF UVEAL MELANOMA
$233,377University Of Illinois At Chicago · R01 · FY2000 · EY
Type-1 Antigen Presenting Cells in CNS Tumors - Key to Efficient Anti-Tumor T-Cel
$233,372Hideho Okada · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Dietary methionine restriction as a therapeutic strategy for metastatic melanoma
$233,347Isabelle Racine Miousse · University Of Arkansas At Fayetteville · P20 · FY2024 · GM
EASTERN COOPERATIVE ONCOLOGY GROUP
$233,272Mayo Clinic Coll Of Medicine, Rochester · U10 · FY2003 · CA
Investigation of autoimmune anti-retinal antibodies in diabetes
$233,250John Heckenlively · University Of Michigan At Ann Arbor · R21 · FY2012 · EY